BAFNA PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 532989     NSE : BAFNAPH    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
May 27,2022
Price(EOD): β‚Ή 122.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 289.61 Cr
Value of β‚Ή 1 Lac invested in BAFNA PHARMACEUTICALS
on May 29,2017 (price: β‚Ή 24.75)

β‚Ή 1 L

β‚Ή 4.94 L

1W : -5.3% 1M : -7.6% 1Y : -14.4%
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
BAFNA PHARMACEUTICALS -5.3% -7.6% -14.4%
SUN PHARMACEUTICAL INDUSTRIES -1.9% -0.2% 29.4%
DIVIS LABORATORIES -9.8% -22.2% -15.5%
DR REDDYS LABORATORIES 2.8% 7.7% -17.4%
CIPLA -0.4% -1.1% 3.1%
GLAND PHARMA -2.5% -7.7% -13%
PIRAMAL ENTERPRISES -12.8% -23.8% 9.1%
CADILA HEALTHCARE 3.1% 8.4% -40.1%
TORRENT PHARMACEUTICALS 12.4% 8.5% 6.5%

FUNDAMENTAL ANALYSIS OF BAFNA PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Mar2020, Y: Mar2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BAFNA PHARMACEUTICALS

 
Valuation Score
[As on : May 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
-
P/E Calculated based on EPS of -9.17
[ Mar2020 - Consolidated Results ]

-
P/B Calculated based on Book Value of -17.93
[ Mar2020 - Consolidated Results ]

6.82
P/S Calculated based on Revenues of 42.472 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF BAFNA PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
316%
805%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BAFNA PHARMACEUTICALS


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

BAFNA PHARMACEUTICALS vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BAFNA PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.27
-0.68
2.22
0.6
-
-0.71
2.43
0.57
[Last Annual Data : Mar2020]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BAFNA PHARMACEUTICALS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BAFNA PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
20.21%
1820.81%
109.76%
102.71%
0.44%
262.2%
1781.9%
860.32%
QtrlyTrend
8
Latest Qtr: Mar2020
Quarterly Result Analysis →


BAFNA PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about BAFNA PHARMACEUTICALS


Is BAFNA PHARMACEUTICALS good for long term investment?

As on May 27,2022, the Fundamentals of BAFNA PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of BAFNA PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BAFNA PHARMACEUTICALS UnderValued or OverValued?

As on May 27,2022, BAFNA PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of BAFNA PHARMACEUTICALS ?

As on May 27,2022, the Intrinsic Value of BAFNA PHARMACEUTICALS is Rs. 21.44 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -113.72
Fair Value [Median EV / Sales Model] : Rs. 29.38
Fair Value [Median Price / Sales Model] : Rs. 13.50
Median Fair Value of BAFNA PHARMACEUTICALS : Rs. 21.44

Is BAFNA PHARMACEUTICALS trading at a Premium or Discount?

As on May 27,2022, BAFNA PHARMACEUTICALS is trading at a Premium of 470% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z